Menarini Silicon Biosystems has announced the publication of important findings from the PACE trial, focusing on the clinical utility of counting Circulating Tumor Cells...
A recent study from the University of Manchester has uncovered genetic variants that may explain why some prostate cancer patients experience increased sensitivity to...